Certified by Founder Lodge
Smartlens
United States - Mountain View, California
START UP
1 Disclosed Funding Rounds $6,100,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Smartlens is a clinical-stage company with its portfolio of innovative technologies for diagnosing and treating glaucoma, a chronic eye disease that ranks as the leading cause of irreversible
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 12 ,2023 | Series A | $6,100,000 | |
| October, 15 ,2025 | Unknown | $5,200,000.00 |
Graphene Ventures
Boutique Venture Partners
Ambit Health Ventures
3E Bioventures Capital
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
Onsetto | $2,200,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
